Results 181 to 190 of about 2,597,035 (295)

Beyond Joint Hypermobility: Investigating Bladder Dysfunction in Hypermobile Ehlers‐Danlos Syndrome

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Introduction and Objectives Hypermobile Ehlers‐Danlos Syndrome (hEDS) is the most common subtype of Ehlers‐Danlos Syndrome, a group of connective tissue disorders caused by collagen abnormalities. While musculoskeletal features of hEDS are well characterized, its impact on visceral organs, including the bladder, remains underexplored.
Marium Ansari   +5 more
wiley   +1 more source

Perioperative cognitive dysfunction in bladder cancer patients, causal factors, and possible interventions. [PDF]

open access: yesFront Med (Lausanne)
Cicvaric A   +6 more
europepmc   +1 more source

Diabetes‐Induced Dysregulation of Purinergic Signaling in the Bladder Mucosa: Accelerated ATP Hydrolysis and Impaired Adenosine Uptake Promote Underactive Bladder Phenotype

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Objective To explore molecular mechanisms underlying excessive extracellular adenosine (ADO) accumulation in the bladder lamina propria (LP) of mice with type 2 diabetes (T2D) induced by a high‐fat, high‐sucrose diet (HFHSD), conceivably leading to bladder underactivity.
Mahsa Borhani Peikani   +2 more
wiley   +1 more source

A Framework Analysis of Electronic Bladder Diary Apps: Suitability for Clinical Decision‐Making and Comparison to Validated Paper Diaries

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Bladder diaries aid physicians in diagnosis and treatment of lower urinary tract symptoms and bladder conditions, but perceived burden of documentation can compromise completion of paper diaries. Perceived benefits of electronic diaries over paper diaries include ease of use and the option to export and share data. The aim of this
Ceilidh Matthews   +4 more
wiley   +1 more source

Hodgkin's Disease Involving the Urinary Bladder: A Case Report

open access: yesAnnals of Saudi Medicine, 1991
E M, Ibrahim   +4 more
openaire   +2 more sources

The Benefits of Adding Non‐Antimuscarinic Pharmaceuticals in Combination With Beta‐3 Agonists for Overactive Bladder Treatment: A Systematic Review

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Antimuscarinics, as the current first‐line pharmacologic therapies for overactive bladder, exhibit low patient adherence and high rates of reported side effects. As a modern alternative pharmaceutical treatment, beta‐3 agonists, which relax the urinary bladder, may be more tolerable for patients, increasing adherence and ...
Felicity Smith   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy